CALVIRI, INC.
Blood-based diagnostic assay using peptide microarray to measure immune reactivity against frameshift peptides for microsatellite instability (MSI) status detection
- Sector
- Medtech
- Headquarters
- Tempe, AZ
- Founded
- 2015
- Latest Form D
- $785K, Nov 2024
- Total capital
- $11.4M
- Federal grants
- $300K
- 1 award · 2019
- Rank in peer group#9 of 68
- Private capital raised
- $11.1M
- 7 Form D · last Nov 2024
- 23 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 11 pending · first 2017
- Rank in peer group#8 of 68
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$785K
- Private capital raisedForm D · SEC · 6th filing$150K
- Private capital raisedForm D · SEC · 5th filing$650K
- Private capital raisedForm D · SEC · 4th filing$5.2M
- Private capital raisedForm D · SEC · 3rd filing$2.4M
- Private capital raisedForm D · SEC · 2nd filing$430K
- Federal grantHealth and Human S · Phase I · A Simple Blood Test for Microsatellite Instability Status$300K
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 68 peers
Line = medianMedtech · Instrument
- Federal grants#9 · top 13%
- Granted patents#8 · top 12%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Kathryn Albert SykesResearcherDirectorLinked by $300K in grants as PI
- Anna Albert BarkerDirectorNamed in SEC Form D filings
- George Albert PosteDirectorNamed in SEC Form D filings
- Jacque J. SokolovDirectorNamed in SEC Form D filings
- Jeff J. Le BengerDirectorNamed in SEC Form D filings
- Jeffrey J. Le BengerDirectorNamed in SEC Form D filings
Show all 11 people
- Marc J. WolffExecutive Officer, DirectorNamed in SEC Form D filings
- Michael J. ChambersDirectorNamed in SEC Form D filings
- Michael J. McCallisterDirectorNamed in SEC Form D filings
- Neal Albert WoodburyDirectorNamed in SEC Form D filings
- Stephen Albert JohnstonExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 13- PendingIdentification And Use Of Novopeptides For The Treatment Of CancerUSPTOApplication 17450318
- GrantedIdentification And Use Of Novopeptides For The Treatment Of CancerUSPTOUS 11,168,121
- GrantedIdentification And Use Of Novopeptides For The Treatment Of CancerUSPTOUS 9,732,131
Show all 13 patent records
- Identification And Use Of Novopeptides For The Treatment Of CancerMay 26, 2022 · Application 17450318Pending
- Identification And Use Of Novopeptides For The Treatment Of CancerNov 9, 2021 · US 11,168,121Granted
- Identification And Use Of Novopeptides For The Treatment Of CancerAug 15, 2017 · US 9,732,131Granted
- Compositions, Systems And Methods For Determining Health StatusApplication 63638786Pending
- Non-coding Rna Peptide Antigens For Cancer Vaccines, Therapeutics, And DiagnosticsApplication PCTUS2024021622Pending
- Tryptophan Neoantigen Peptides For Diagnostics, Therapeutics, And VaccinesApplication PCTUS2024015795Pending
- Methods And Compositions For Reducing Non-tumor DiseaseApplication 63627933Pending
- Non-coding Rna Peptide Antigens For Cancer Vaccines, Therapeutics, And DiagnosticsApplication 63492907Pending
- Tryptophan Frameshift Peptides For Diagnostics, Therapeutics, And VaccinesApplication 63485735Pending
- Non-coding Rna Peptide Antigens For Cancer Vaccines, Therapeutics, And DiagnosticsApplication 19469099Pending
- Tryptophan Neoantigen Peptides For Diagnostics, Therapeutics, And VaccinesApplication 19155897Pending
- Compositions, Systems And Methods For Determining Health StatusApplication PCTUS2025026213Pending
- Methods And Compositions For Reducing Non-tumor DiseaseApplication PCTUS2025013707Pending
Related companies, and why
- BIACURE THERAPIES, INC.Similar federal contract value in Medtech · null in contracts
- Intuitive Biosciences, Inc.Similar federal contract value in Medtech · null in contracts
- Precede BiosciencesSimilar federal contract value in Medtech · null in contracts
- IVIEW Therapeutics IncSimilar federal contract value in Medtech · null in contracts
- SENTIAR, INC.Similar federal contract value in Medtech · null in contracts
- ZETAGEN THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .